Filing Details
- Accession Number:
- 0001179110-10-001502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-26 12:00:00
- Reporting Period:
- 2010-01-22
- Filing Date:
- 2010-01-26
- Accepted Time:
- 2010-01-26 17:30:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1294276 | Ram Sasisekharan | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-22 | 25,000 | $15.01 | 381,344 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2008.